AR084505A1 - Derivados de 5-metil-1-(naftalen-2-il)-1h-pirazol - Google Patents

Derivados de 5-metil-1-(naftalen-2-il)-1h-pirazol

Info

Publication number
AR084505A1
AR084505A1 ARP110104503A ARP110104503A AR084505A1 AR 084505 A1 AR084505 A1 AR 084505A1 AR P110104503 A ARP110104503 A AR P110104503A AR P110104503 A ARP110104503 A AR P110104503A AR 084505 A1 AR084505 A1 AR 084505A1
Authority
AR
Argentina
Prior art keywords
derivatives
formula
naftalen
pirazol
methyl
Prior art date
Application number
ARP110104503A
Other languages
English (en)
Inventor
Maria Rosa Cuberes-Altisent
Jover Antoni Torrens
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of AR084505A1 publication Critical patent/AR084505A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a derivados de pirazol de fórmula (1) que tienen actividad farmacológica, procedimientos de preparación de tales compuestos, a composiciones farmacéuticas que los comprenden, y a su uso en la terapia y/o la profilaxis de dolor.Reivindicación 1: Compuesto de la fórmula (1) en la que R1 y R2 se seleccionan independientemente del grupo que consiste en alquilo C1-6 sustituido o no sustituido, halógeno, hidroxilo y alcoxilo C1-6; n y m se seleccionan independientemente de 0, 1 y 2; la línea discontinua (representada por - - - - -) representa un doble enlace opcional o un solvato, profármaco, isómero o sal farmacéuticamente aceptable del mismo.
ARP110104503A 2010-12-03 2011-12-02 Derivados de 5-metil-1-(naftalen-2-il)-1h-pirazol AR084505A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10382326A EP2460804A1 (en) 2010-12-03 2010-12-03 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics

Publications (1)

Publication Number Publication Date
AR084505A1 true AR084505A1 (es) 2013-05-22

Family

ID=43500092

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104503A AR084505A1 (es) 2010-12-03 2011-12-02 Derivados de 5-metil-1-(naftalen-2-il)-1h-pirazol

Country Status (11)

Country Link
US (1) US8729073B2 (es)
EP (2) EP2460804A1 (es)
JP (1) JP5860895B2 (es)
CN (1) CN103261192B (es)
AR (1) AR084505A1 (es)
CA (1) CA2819389A1 (es)
ES (1) ES2573315T3 (es)
HK (1) HK1190145A1 (es)
MX (1) MX340585B (es)
TW (1) TW201305148A (es)
WO (1) WO2012072781A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP2818166A1 (en) * 2013-06-26 2014-12-31 Laboratorios del Dr. Esteve S.A. Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (IC/BPS)
MA39147B1 (fr) 2013-12-17 2019-12-31 Esteve Labor Dr Combinaisons d'inhibiteurs de la recapture de sérotonine-norépinéphrine (snri) et de ligands des récepteurs sigma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020005A1 (en) * 1998-10-01 2000-04-13 EGIS Gyógyszergyár Rt. Pharmaceutical compositions containing an opiate analgesic and a synergizing substance
EP1634872A1 (en) * 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
EP2325174A1 (en) * 2004-08-27 2011-05-25 Laboratorios Del. Dr. Esteve, S.A. Sigma receptor inhibitors
EP1994032A1 (en) 2006-03-01 2008-11-26 Laboratorios del Dr. Esteve S.A. Pyrazole derivatives as sigma receptor inhibitors
EP2113501A1 (en) * 2008-04-25 2009-11-04 Laboratorios Del. Dr. Esteve, S.A. 5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors

Also Published As

Publication number Publication date
JP5860895B2 (ja) 2016-02-16
EP2646435A1 (en) 2013-10-09
CN103261192A (zh) 2013-08-21
HK1190145A1 (zh) 2014-06-27
ES2573315T3 (es) 2016-06-07
MX340585B (es) 2016-07-15
CA2819389A1 (en) 2012-06-07
CN103261192B (zh) 2016-08-10
EP2646435B1 (en) 2016-03-02
US20130303540A1 (en) 2013-11-14
MX2013006004A (es) 2013-07-15
JP2013544270A (ja) 2013-12-12
TW201305148A (zh) 2013-02-01
US8729073B2 (en) 2014-05-20
EP2460804A1 (en) 2012-06-06
WO2012072781A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
AR084505A1 (es) Derivados de 5-metil-1-(naftalen-2-il)-1h-pirazol
CY1124117T1 (el) Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων
UY38297A (es) Compuestos derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona, composiciones, métodos y usos de los mismos
AR056873A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas
AR092269A1 (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
CY1118879T1 (el) Ενωσεις τριαζινης ως αναστολεις κινασης ρ13 και mtor
PE20181093A1 (es) Compuestos heterociclicos y usos de los mismos
AR097079A1 (es) SALES DE DERIVADOS DE 2-AMINO-1-HIDROXIETIL-8-HIDROXIQUINOLIN-2(1H)-ONA QUE TIENEN ACTIVIDAD ANTAGONISTA DE RECEPTORES MUSCARÍNICOS ASÍ COMO ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO
CU20110145A7 (es) Derivados de sulfonamida
EA201592144A1 (ru) Производное фенола, способ его получения и его применение в медицине
UY32490A (es) Inhibidores de beta-secretasa
AR083879A1 (es) Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos
BR112016016844A2 (pt) Compostos heterocíclicos
AR081426A1 (es) Derivados de pirazol inhibidores del receptor sigma
BR112016010080A8 (pt) compostos de pirazolopirimidina, composição farmacêutica e seu uso
CO6690768A2 (es) Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7
CL2015002520A1 (es) Compuestos novedosos de pirimidina y piridina y su uso.
HRP20170873T1 (hr) Monociklički derivat piridina
AR070299A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas, usos y composiciones farmaceuticas
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
AR073551A1 (es) Pirimidinas macrociclicas como inhibidores de proteina cinasa
TR201802944T4 (tr) İlaç olarak azai̇ndazol veya di̇azai̇ndazol türünün türevleri̇
CL2008001669A1 (es) Compuestos derivados de piperidina/piperazina inhibidora de dgat-1; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento de la obesidad, dislipidemia, fibrosis hepatica y diabetes tipo ii, entre otras.
BR112015023705A2 (pt) composto da fórmula (ia) ou um sal, hidrato, solvato ou forma cristalina farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composto e método para síntese do composto da fórmula (ia)
MY196788A (en) Fused tricyclic ?-amino acid derivative, preparation method therefor, and medical use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal